Clinical evaluations of cell‐free fetal <scp>DNA</scp> quantities in pre‐eclamptic pregnancies

Abstract

Cell-free fetal DNA in maternal blood could be used as a marker for identifying subjects at increased risk of developing pre-eclampsia.